期刊
SUPPORTIVE CARE IN CANCER
卷 13, 期 2, 页码 104-108出版社
SPRINGER
DOI: 10.1007/s00520-004-0700-8
关键词
delayed emesis; moderately emetogenic chemotherapy; dexamethasone; 5-HT3 antagonist
Data on the incidence and efficacy of antiemetic prophylaxis against delayed emesis induced by moderately emetogenic chemotherapy are scanty. An overview of the literature has been done that showed the efficacy of dexamethasone in two of three randomized trials. Its optimal dose and duration of administration has not been defined. Only one of four randomized studies showed a statistically significant efficacy of 5-HT3 antagonists. Finally, only weak evidence has been published on the efficacy of dopamine receptor antagonists.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据